AstraZeneca signs AI drug discovery deal with insitro worth up to $1.86 billion

This collaboration highlights the growing reliance on AI in pharma, potentially accelerating drug discovery and reshaping industry dynamics. The post AstraZeneca signs AI drug discovery deal with insitro worth up to $1.86 billion appeared first on Crypto Briefing.